101 related articles for article (PubMed ID: 2004026)
1. Interleukin 2 infusion induces haemopoietic growth factors and modifies marrow regeneration after chemotherapy or autologous marrow transplantation.
Heslop HE; Duncombe AS; Reittie JE; Bello-Fernandez C; Gottlieb DJ; Prentice HG; Mehta AB; Hoffbrand AV; Brenner MK
Br J Haematol; 1991 Feb; 77(2):237-44. PubMed ID: 2004026
[TBL] [Abstract][Full Text] [Related]
2. In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous marrow transplantation.
Heslop HE; Gottlieb DJ; Bianchi AC; Meager A; Prentice HG; Mehta AB; Hoffbrand AV; Brenner MK
Blood; 1989 Sep; 74(4):1374-80. PubMed ID: 2504308
[TBL] [Abstract][Full Text] [Related]
3. Malignant plasma cells are sensitive to LAK cell lysis: pre-clinical and clinical studies of interleukin 2 in the treatment of multiple myeloma.
Gottlieb DJ; Prentice HG; Mehta AB; Galazka AR; Heslop HE; Hoffbrand AV; Brenner MK
Br J Haematol; 1990 Aug; 75(4):499-505. PubMed ID: 2119792
[TBL] [Abstract][Full Text] [Related]
4. A phase I clinical trial of recombinant interleukin 2 following high dose chemo-radiotherapy for haematological malignancy: applicability to the elimination of minimal residual disease.
Gottlieb DJ; Brenner MK; Heslop HE; Bianchi AC; Bello-Fernandez C; Mehta AB; Newland AC; Galazka AR; Scott EM; Hoffbrand AV
Br J Cancer; 1989 Oct; 60(4):610-5. PubMed ID: 2803933
[TBL] [Abstract][Full Text] [Related]
5. Generation of anti-tumour activity by OKT3-stimulation in multiple myeloma: in vitro inhibition of autologous haemopoiesis.
Attisano C; Bianchi A; Montacchini L; Carlesso N; Peola S; Bruno B; Roux V; Ferrero D; Gallo E; Boccadoro M
Br J Haematol; 1994 Jul; 87(3):494-502. PubMed ID: 7993789
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
[TBL] [Abstract][Full Text] [Related]
7. Colony stimulating activity in the serum of patients with multiple myeloma is enhanced by interleukin 3: a possible role for interleukin 3 after high dose melphalan and autologous bone marrow transplantation for multiple myeloma.
Millar BC; Bell JB; Montes A; Millar JL; Maitland JA; Treleaven J; Viner C; Gore M; McElwain TJ
Br J Haematol; 1990 Jul; 75(3):366-72. PubMed ID: 2201402
[TBL] [Abstract][Full Text] [Related]
8. Peripheral blood and bone marrow immunophenotypic and functional modifications induced in acute leukemia patients treated with interleukin 2: evidence of in vivo lymphokine activated killer cell generation.
Foa R; Guarini A; Gillio Tos A; Cardona S; Fierro MT; Meloni G; Tosti S; Mandelli F; Gavosto F
Cancer Res; 1991 Feb; 51(3):964-8. PubMed ID: 1988139
[TBL] [Abstract][Full Text] [Related]
9. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
10. IL2 activated killer cells may contribute to cytomegalovirus induced marrow hypoplasia after bone marrow transplantation.
Duncombe AS; Grundy JE; Prentice HG; Brenner MK
Bone Marrow Transplant; 1991 Feb; 7(2):81-7. PubMed ID: 1646663
[TBL] [Abstract][Full Text] [Related]
11. Short-term liquid marrow cultures are supported by a mixture of haematopoietic cytokines but do not purge for acute myeloid or lymphoid leukemic marrow cells.
Johnsen HE; Gaarsdal E; Jensen L; Philip P; Hansen NE
Leukemia; 1993 Sep; 7(9):1402-8. PubMed ID: 8371591
[TBL] [Abstract][Full Text] [Related]
12. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) in serum in bone marrow transplanted patients.
Sallerfors B; Olofsson T; Lenhoff S
Bone Marrow Transplant; 1991 Sep; 8(3):191-5. PubMed ID: 1720339
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous and interleukin 2 induced secretion of tumour necrosis factor and gamma interferon following autologous marrow transplantation or chemotherapy.
Heslop HE; Gottlieb DJ; Reittie JE; Bello-Fernandez C; Meager A; Prentice HG; Brenner MK
Br J Haematol; 1989 Jun; 72(2):122-6. PubMed ID: 2503022
[TBL] [Abstract][Full Text] [Related]
15. Recombinant interleukin-2 treatment before and after autologous stem cell transplantation in hematologic malignancies: clinical and immunologic effects.
De Laurenzi A; Iudicone P; Zoli V; De Rosa L; Guglielmetti M; Pescarollo A; Papetti C; Pacilli L; Lapponi P; Petti N
J Hematother; 1995 Apr; 4(2):113-20. PubMed ID: 7633841
[TBL] [Abstract][Full Text] [Related]
16. GM-CSF therapy for delayed engraftment after autologous bone marrow transplantation.
Brandwein JM; Nayar R; Baker MA; Sutton DM; Scott JG; Sutcliffe SB; Keating A
Exp Hematol; 1991 Mar; 19(3):191-5. PubMed ID: 1995310
[TBL] [Abstract][Full Text] [Related]
17. Culture of normal and leukemic bone marrow in interleukin-2: analysis of cell activation, cell proliferation, and cytokine production.
Klingemann HG; Neerunjun J; Schwulera U; Ziltener HJ
Leukemia; 1993 Sep; 7(9):1389-93. PubMed ID: 8371589
[TBL] [Abstract][Full Text] [Related]
18. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
Lemoli RM; Cavo M; Fortuna A
J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
[TBL] [Abstract][Full Text] [Related]
19. Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia.
Demirer T; Petersen FB; Bensinger WI; Appelbaum FR; Fefer A; Rowley S; Sanders J; Chauncey T; Storb R; Lilleby K; Buckner CD
Bone Marrow Transplant; 1996 Jul; 18(1):29-34. PubMed ID: 8831992
[TBL] [Abstract][Full Text] [Related]
20. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
Papadakis V; Ferguson KF; Heller G; Kernan NA
Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
